Literature DB >> 1939830

Kinetics of bone-resorbing activity in developing periapical lesions.

C Y Wang1, P Stashenko.   

Abstract

The presence and kinetics of bone-resorbing activity in periapical lesions were studied with a rat model system. Lesions were found to expand most rapidly between induction on day 0 and day 15 ("active phase"), with enlargement occurring at a slower rate thereafter (days 20 and 30, "chronic phase"), as assessed by measurement of magnified radiographs and automated image analysis. Pooled extracts of periapical tissues obtained on day 15 contained significant levels of bone-resorbing activity, as determined by 45Ca release from pre-labeled fetal rat long bones. Normal rat dental pulp and periodontal ligament contained no activity. In two kinetic experiments, highest levels of bone-resorbing activity were detected in tissues on days 10 (10.4% and 11.6% specific 45Ca release/mg/mL) and 15 (8.9%). Activity declined thereafter on day 20 (4.4% and 6.1%) to near baseline levels by day 30 (1.4% and 3.3%). Identical levels of resorbing activity were found in the presence or absence of polymyxin-B, an inhibitor of bacterial lipopolysaccharide. These findings demonstrate that bone-resorbing activity is temporarily related to periapical bone destruction and suggest that this model may be useful for studies of mediators that are involved in the pathogenesis of inflammatory bone resorption.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1939830     DOI: 10.1177/00220345910700100901

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  7 in total

1.  OPG-Fc but Not Zoledronic Acid Discontinuation Reverses Osteonecrosis of the Jaws (ONJ) in Mice.

Authors:  Rafael Scaf de Molon; Hiroaki Shimamoto; Olga Bezouglaia; Flavia Q Pirih; Sarah M Dry; Paul Kostenuik; Rogely W Boyce; Denise Dwyer; Tara L Aghaloo; Sotirios Tetradis
Journal:  J Bone Miner Res       Date:  2015-05-27       Impact factor: 6.741

2.  Interleukin-6 deficiency increases inflammatory bone destruction.

Authors:  K Balto; H Sasaki; P Stashenko
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

3.  RANKL inhibitors induce osteonecrosis of the jaw in mice with periapical disease.

Authors:  Tara L Aghaloo; Simon Cheong; Olga Bezouglaia; Paul Kostenuik; Elisa Atti; Sarah M Dry; Flavia Q Pirih; Sotirios Tetradis
Journal:  J Bone Miner Res       Date:  2014-04       Impact factor: 6.741

4.  Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice.

Authors:  Ben Kang; Simon Cheong; Thawinee Chaichanasakul; Olga Bezouglaia; Elisa Atti; Sarah M Dry; Flavia Q Pirih; Tara L Aghaloo; Sotirios Tetradis
Journal:  J Bone Miner Res       Date:  2013-07       Impact factor: 6.741

5.  Immunomodulation Mediated by Azithromycin in Experimental Periapical Inflammation.

Authors:  Ana Cristina Andrada; Mariane Maffei Azuma; Hisako Furusho; Kimito Hirai; Shuang Xu; Robert R White; Hajime Sasaki
Journal:  J Endod       Date:  2020-08-05       Impact factor: 4.171

6.  The influence of mineral trioxide aggregate on adaptive immune responses to endodontic pathogens in mice.

Authors:  Taia Maria Berto Rezende; Leda Quercia Vieira; Antônio Paulino Ribeiro Sobrinho; Ricardo Reis Oliveira; Martin A Taubman; Toshihisa Kawai
Journal:  J Endod       Date:  2008-09       Impact factor: 4.171

7.  Chronic apical periodontitis exacerbates atherosclerosis in apolipoprotein E-deficient mice and leads to changes in the diversity of gut microbiota.

Authors:  Guowu Gan; Beibei Lu; Ren Zhang; Yufang Luo; Shuai Chen; Huaxiang Lei; Yijun Li; Zhiyu Cai; Xiaojing Huang
Journal:  Int Endod J       Date:  2021-11-16       Impact factor: 5.165

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.